The world's version Delta of COVID-19, is Kosovo also at risk?

The “Delta” that originally has been detected in India has become the world's dominant coronary version, which according to Kosovo experts can soon reach us too. The Delta version is estimated to be approximately 60% more transmitted than the Alpha version, or Kent. The World Health Organization has also classified this version [...]
The Delta version is estimated to be approximately 60% more transmitted than the Alpha version, or Kent. The World Health Organization, however, has also classified this option as the most easily distributed disturbing option.
From the World Health Organization warned that the Delta variant is “ready to grasp” across Europe, as dozens of countries have lifted restrictions.
Foreign media report that people infected by variant Delta are twice as likely to end up in hospital as those infected with Alpha variant. Like the original version of this virus, however, the Delta version is more dangerous for the elderly and those with other health problems.
And symptoms of infection with this option are the same as those of other variants: Ethe, coughing, panting, fatigue, diarrhea, headaches and body.
But how endangered is Kosovo by this option?
Kosovo microbiologist Lul Raka has spoken about the Delta variant in Kosovo, adding that there are still no recorded cases, but does not exclude his arrival.
There is no version Delta in Kosovo that spreads faster than the original option. But that does not mean that it will not reach a near future. From what we've seen in Great Britain, we've had growth and this has been mainly in the young age and in the persons that haven't been vaccinated or done all of the vaccination with two doses of”, Raka said today at a media conference.
We remember that a study conducted by Britain's government resulted in Pfizer and AstraZeneca vaccines being very effective against the Delta version.
According to the study, Pfizer vaccine was 8.8% effective against symptoms two weeks after the second dose, and AstraZeneca vaccine was 60% effective two weeks after the second dose.











